-
Loading metrics
Open Access
Peer-reviewed
Research Article
F11R Is a Novel Monocyte Prognostic Biomarker for Malignant Glioma
-
Winnie W. Pong,
Affiliation Department of Neurology, Washington University School of Medicine, St. Louis, Missouri, United States of America
⨯ -
Jason Walker,
Affiliation The Genome Institute, Washington University School of Medicine, St. Louis, Missouri, United States of America
⨯ -
Todd Wylie,
Affiliation The Genome Institute, Washington University School of Medicine, St. Louis, Missouri, United States of America
⨯ -
Vincent Magrini,
Affiliation The Genome Institute, Washington University School of Medicine, St. Louis, Missouri, United States of America
⨯ -
Jingqin Luo,
Affiliation Division of Biostatistics, Washington University School of Medicine, St. Louis, Missouri, United States of America
⨯ -
Ryan J. Emnett,
Affiliation Department of Neurology, Washington University School of Medicine, St. Louis, Missouri, United States of America
⨯ -
Jaebok Choi,
Affiliation Division of Oncology, Department of Medicine, Washington University School of Medicine, St. Louis, Missouri, United States of America
⨯ -
Matthew L. Cooper,
Affiliation Division of Oncology, Department of Medicine, Washington University School of Medicine, St. Louis, Missouri, United States of America
⨯ -
Malachi Griffith,
Affiliation The Genome Institute, Washington University School of Medicine, St. Louis, Missouri, United States of America
⨯ -
Obi L. Griffith,
Affiliation The Genome Institute, Washington University School of Medicine, St. Louis, Missouri, United States of America
⨯ -
Joshua B. Rubin,
Affiliation Department of Pediatrics, Division of Pediatric Hematology/Oncology, Washington University School of Medicine, St. Louis, Missouri, United States of America
⨯ -
Gregory N. Fuller,
Affiliation Department of Pathology, MD Anderson Cancer Center, Houston, Texas, United States of America
⨯ -
David Piwnica-Worms,
Affiliation BRIGHT Institute and Mallinckrodt Institute of Radiology, Washington University School of Medicine, St. Louis, Missouri, United States of America
⨯ -
Xi Feng,
Affiliation Department of Stem Cell Biology and Regeneration, Cleveland Clinic Foundation, Cleveland, Ohio, United States of America
⨯ -
Dolores Hambardzumyan,
Affiliation Department of Stem Cell Biology and Regeneration, Cleveland Clinic Foundation, Cleveland, Ohio, United States of America
⨯ -
John F. DiPersio,
Affiliation Division of Oncology, Department of Medicine, Washington University School of Medicine, St. Louis, Missouri, United States of America
⨯ -
Elaine R. Mardis,
Affiliation The Genome Institute, Washington University School of Medicine, St. Louis, Missouri, United States of America
⨯ - [ ... ],
-
David H. Gutmann
* E-mail: gutmannd@neuro.wustl.edu
Affiliation Department of Neurology, Washington University School of Medicine, St. Louis, Missouri, United States of America
⨯ - [ view all ]
- [ view less ]
F11R Is a Novel Monocyte Prognostic Biomarker for Malignant Glioma
- Winnie W. Pong,
- Jason Walker,
- Todd Wylie,
- Vincent Magrini,
- Jingqin Luo,
- Ryan J. Emnett,
- Jaebok Choi,
- Matthew L. Cooper,
- Malachi Griffith,
- Obi L. Griffith
- Published: October 11, 2013
- https://doi.org/10.1371/journal.pone.0077571